Aims: Nuclear imaging may have an increasing role in the diagnosis of hepatocellular
carcinoma (HCC). The aim of this study was to compare prospectively the Gallium‐67 citrate …

Because 18F-FDG PET has insufficient sensitivity for the detection of hepatocellular
carcinoma (HCC), 11C-acetate PET has been proposed as another technique for this use …

It is well known that [18F] FDG PET has a low sensitivity in the detection of hepatocellular
carcinoma (HCC). We prospectively compared [11C] acetate PET/CT results with those of …

Objective: The sensitivity of FDG at PET examination of Hepatocellular Carcinoma (HCC) is
restricted. In a few studies, all done in Oriental patients, PET-examination with 11 C-acetate …

It is well known that 18F-FDG PET has a high average false-negative rate of 40%–50% in
the detection of hepatocellular carcinoma (HCC). This is not an acceptable accuracy …

While cross-sectional imaging with computed tomography (CT) and magnetic resonance
imaging is the primary method for diagnosing hepatocellular carcinoma (HCC), they provide …

Purpose The aim of the study was to evaluate the feasibility of using the hepatocyte-specific
positron emission tomography (PET) tracer 2-[18 F] fluoro-2-deoxy-D-galactose (FDGal) as a …

We have reported previously that 11C-acetate (11C-ACT) PET was complementary to 18F-
FDG PET in the evaluation of primary hepatocellular carcinoma (HCC) in relation to the …

Methods We retrospectively studied HCC patients who underwent (18) F-FDG-PET between
June 2001 and February 2005 in Korea National Cancer Center. Thirty-two patients were …

Abstract Background & Aims Positron emission tomography (PET) with the liver‐specific
tracer [18F]‐fluoro‐2‐deoxy‐D‐galactose (18F‐FDGal) can be used for imaging of …